Outcomes and risk factors of second allogeneic haematopoietic stem cell transplantation in patients with relapsed haematological malignancy after first transplantation

Ähnliche Einträge

• The clinical features, risk factors and outcomes of polyomavirus encephalitis after allogeneic haematological stem cell transplantation
  von: Xu‐Ying Pei, et al.
  Veröffentlicht: (2025)
• Monitoring the KMT2A gene post‐chemotherapy independently predicts the relapse and survival risk after allogeneic haematopoietic stem cell transplantation
  von: Jing Liu, et al.
  Veröffentlicht: (2025)
• Clinical features and prognostic model for viral encephalitis after allogeneic haematopoietic stem cell transplantation
  von: Jin Wu, et al.
  Veröffentlicht: (2024)
• Venetoclax therapy in chronic lymphocytic leukaemia patients relapsed after allogeneic haematopoietic stem cell transplantation
  von: Francesca Perutelli, et al.
  Veröffentlicht: (2025)
• Correction to ‘Genetic testing to identify hereditary predispositions to haematological malignancy is critical prior to allogenic haematopoietic cell transplant’
  Veröffentlicht: (2025)